Selpercatinib ' Poised to Alter the Landscape ' of RET+ve Cancers Selpercatinib ' Poised to Alter the Landscape ' of RET+ve Cancers
Selpercatinib induced high response rates in patients with RET-altered non-small cell lung cancer and medullary thyroid cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Thyroid | Thyroid Cancer